ArticleBlood advances2022
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell-mediated tumor responses.
John Daly et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
51 papers cite it
this papercites it